ACADIA Pharmaceuticals Overview

  • Founded
  • 1993

Founded
  • Status
  • Public

  • Employees
  • 500

Employees
  • Stock Symbol
  • ACAD

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $16.96

  • (As of Tuesday Closing)

ACADIA Pharmaceuticals General Information

Description

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 12830 El Camino Real
  • Suite 400
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACADIA Pharmaceuticals Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$16.96 $16.60 $12.24 - $28.05 $2.69B 162M 2.7M -$1.27

ACADIA Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 1,892,985 3,277,580 7,903,728 5,915,630
Revenue 512,401 484,145 441,755 339,076
EBITDA (202,225) (164,766) (284,651) (242,782)
Net Income (204,618) (167,870) (281,584) (235,259)
Total Assets 612,766 700,122 782,616 783,183
Total Debt 63,717 64,430 49,547 9,795
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ACADIA Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ACADIA Pharmaceuticals‘s full profile, request access.

Request a free trial

ACADIA Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address
Pharmaceuticals
San Diego, CA
500 As of 2022
00000
000000&0

0000 0

liquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillu
0000000000000
Cambridge, MA
000 As of 0000
00.000
000000000 00.000

00 000

fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
0000000000000
Paris, France
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACADIA Pharmaceuticals Competitors (60)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SAGE Therapeutics Formerly VC-backed Cambridge, MA 000 00.000 000000000 00.000
00 0000000 Formerly Accelerator/Incubator backed Paris, France 00 000.00 000000000 000.00
000000000 00000000 Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
00000000 000000000 Formerly VC-backed Switzerland 00 00000 000000000 00000
00000000 Venture Capital-Backed New Haven, CT 00 00000 00000000 00000
You’re viewing 5 of 60 competitors. Get the full list »

ACADIA Pharmaceuticals Patents

ACADIA Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210161880-A1 Methods for treating dementia related psychosis Pending 02-Dec-2019 0000000000
US-20200289474-A1 Methods of treating pain with a thiazoline anti-hyperalgesic Abandoned 01-Feb-2019 0000000000
US-20220168279-A1 Methods of treating pain with a thiazoline anti-hyperalgesic Pending 01-Feb-2019 0000000000
US-20200246316-A1 Methods of treating post-surgical pain with a thiazoline anti-hyperalgesic agent Abandoned 01-Feb-2019 0000000000 0
US-20200246318-A1 Methods of treating pain with a thiazoline anti-hyperalgesic Abandoned 01-Feb-2019 A61K31/426
To view ACADIA Pharmaceuticals’s complete patent history, request access »

ACADIA Pharmaceuticals Executive Team (26)

Name Title Board Seat Contact Info
Stephen Davis JD Chief Executive Officer & Board Member
Srdjan Stankovic MD President
Mark Schneyer Chief Financial Officer, Finance & Executive Vice President
Brendan Teehan Chief Operating Officer, Operations & Executive Vice President
James Kihara Chief Accounting Officer, Accounting & Controller, Finance
You’re viewing 5 of 26 executive team members. Get the full list »

ACADIA Pharmaceuticals Board Members (14)

Name Representing Role Since
Daniel Soland Self Board Member 000 0000
Edmund Harrigan MD Self Board Member 000 0000
Elizabeth Garofalo MD Self Board Member 000 0000
Julian Baker Self Board Member 000 0000
Laura Brege ACADIA Pharmaceuticals Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

ACADIA Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACADIA Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Aug-2020 0000000000 000.00 Biotechnology 0000000 0
To view ACADIA Pharmaceuticals’s complete acquisitions history, request access »

ACADIA Pharmaceuticals Subsidiaries (1)

Company Name Industry Location Founded
0000 (000000000000 Biotechnology Skokie, IL 0000
To view ACADIA Pharmaceuticals’s complete subsidiaries history, request access »